Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High Risk Patients
Credit(s): 1.00 (60 min)
9/23/2021 8:30 PM - 9:30 PM ET 9/27/2021 - 8:00 - 9:00 PM ET9/28/2021 - 7:00 - 8:00 PM ET
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
Physicians/ABD MOC – ABD MOC Point(s)
This activity, Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High-Risk Patients, will review emerging trends in diagnosis and risk stratification for patients with common skin cancers, including melanoma and cSCC, including discussion of current diagnostic strategies, challenges in risk stratification, and clinical applications for new molecular tests designed to identify high-risk patients and aid in treatment decision-making.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Managing Advanced Prostate Cancer in the COVID-19 Era: What Do Oncologists Need to Know?
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.